Redcare Pharmacy Q3 2025 Performance and Full-Year Guidance FAQ

What were Redcare Pharmacy’s key Q3 2025 financial results?

Total sales increased 25.2% to EUR 719 million, with non-Rx sales up 16.7% to EUR 448 million and total Rx sales growing 42.3% to EUR 272 million. Year-to-date total sales reached EUR 2.15 billion, up 27% from the previous year.

How did Redcare Pharmacy’s prescription medication business perform in Germany?

German Rx sales showed exceptional growth, increasing 82.1% to EUR 126 million in Q3 2025 compared to Q3 2024. Year-to-date German Rx sales reached EUR 348 million, representing 122% growth.

What is Redcare Pharmacy’s full-year guidance and has it changed?

The company reaffirmed all elements of its full-year guidance, including maintaining its EBITDA margin guidance range of 2 to 2.5% and expecting to achieve at least EUR 500 million in Rx sales for the full year.

How did customer metrics change in Q3 2025?

Active customers increased by 0.2 million to reach 13.7 million, and the Net Promoter Score (NPS) improved significantly to well over 70, compared to 64 in the first half of the current year.

Which geographic segments contributed to Redcare Pharmacy’s growth?

Both reporting segments showed strong performance: DACH segment (Germany, Austria, Switzerland) grew 25.2% to EUR 587 million, while the International segment (Belgium, Italy, France, Netherlands) grew 25.4% to EUR 132 million.

When will Redcare Pharmacy release its full Q3 2025 financial report?

The company will release the full interim report for the third quarter of 2025 on October 29, 2025. The current figures are preliminary and unaudited.

What did the CEO say about the company’s Q3 performance?

CEO Olaf Heinrich stated that the company delivered strong Q3 momentum, particularly in German Rx with double-digit quarter-over-quarter growth, and confirmed that growth remains profitable and cash generative with solid Q3 EBITDA.

Who should investors contact for more information about Redcare Pharmacy’s performance?

Investors can contact Monica Ambrosi, Associate Director of Investor Relations, at [email protected]. For press inquiries, contact Sven Schirmer, Director of Corporate Communications, at [email protected].

Where is Redcare Pharmacy headquartered and in which countries does it operate?

Redcare Pharmacy is headquartered in Sevenum, Netherlands, near Venlo, and operates in seven European countries: Germany, Austria, France, Belgium, Italy, the Netherlands, and Switzerland.